Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,593
NCT01372423
Evaluation of Clinical Equivalence Between Two Lubiprostone Products
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2011
Completion: Jun 30, 2012
NCT01456611
Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%
Start: Sep 30, 2011
Completion: Apr 30, 2012
NCT05363280
Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC
Phase: Phase 2
Start: Nov 1, 2022
Completion: Dec 31, 2026